FunPep Company Limited

Equities

4881

JP3802640007

Biotechnology & Medical Research

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-04-26 am EDT			5-day change	1st Jan Change
146 ^JPY	-1.35%		+2.10%	+8.15%

Mar. 21	FunPep Company Limited announced that it has received ¥199.9998 million in funding from Shionogi & Co., Ltd.	CI
Mar. 04	FunPep Company Limited announced that it expects to receive ¥199.9998 million in funding from Shionogi & Co., Ltd.	CI

FunPep Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2023

November 14, 2023 at 01:00 am EST

FunPep Company Limited reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported net loss was JPY 746 million. Basic loss per share from continuing operations was JPY 31.97.

Latest news about FunPep Company Limited

FunPep Company Limited announced that it has received ¥199.9998 million in funding from Shionogi & Co., Ltd.	Mar. 20	CI
FunPep Company Limited announced that it expects to receive ¥199.9998 million in funding from Shionogi & Co., Ltd.	Mar. 03	CI
FunPep Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2023	Nov. 14	CI
FunPep Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
FunPep Company Limited completed the acquisition of Anti-Aging Peptide Co., Ltd. from Hironori Nakagami , Bio Site Start Fund L.P., Naotaka Hashiya, Chiyako Ueda, ReBeage Co., Ltd. and others.	22-09-30	CI
FunPep Company Limited agreed to acquire Anti-Aging Peptide Co., Ltd. from Hironori Nakagami , Bio Site Start Fund L.P., Naotaka Hashiya, Chiyako Ueda, ReBeage Co., Ltd. and others.	22-07-13	CI
FunPep Company Limited announced that it has received ¥3.741 million in funding from SBI Securities Co., Ltd., Investment Arm	21-12-12	CI
FunPep Company Limited announced that it expects to receive ?3.741 million in funding from SBI Securities Co., Ltd., Investment Arm	21-11-25	CI
FunPep Company Limited has completed an IPO in the amount of ¥1.780805 billion.	20-12-25	CI
FunPep Company Limited has filed an IPO.	20-11-20	CI
FunPep Company Limited has withdrawn its IPO.	20-11-14	CI
FunPep Company Limited has filed an IPO.	19-11-18	CI
FunPep Co., Ltd. announced that it has received ¥460 million in funding from a group of investors	18-10-04	CI
FunPep Co., Ltd. announced that it has received ¥100 million in funding from OSAKA University Venture Capital Co., Ltd.	16-04-13	CI
Funpep Co., Ltd. announced that it has received funding from Japan Science And Technology Agency and other investors.	15-11-29	CI

Chart FunPep Company Limited

Duration

Period

More charts

Company Profile

FunPep Co Ltd is a Japan-based company engaged in the research and development business for pharmaceuticals. The main business is to promote research and development of functional peptides, which are the results of research at the Graduate School of Medicine, Osaka University, and to put them into practical use in the business fields such as pharmaceuticals, cosmetics and medical devices. The business model defines its technical area as a functional peptide-based area and a related area that has synergies with it. The Research & Development pipeline is composed of research themes for antibody-inducing peptides and developed products. The Company is engaged in the sale of peptide active ingredients through cosmetic raw material trading companies or sales companies.

Sector

Biotechnology & Medical Research

Calendar

2024-05-12 - Q1 2024 Earnings Release

More about the company

	1st Jan change	Capi.
FUNPEP COMPANY LIMITED	+8.15%	24.12M
IQVIA HOLDINGS INC.	+1.51%	42.75B
LONZA GROUP AG	+49.22%	41.61B
MODERNA, INC.	+8.57%	41.34B
CELLTRION, INC.	-12.36%	26.59B
ICON PUBLIC LIMITED COMPANY	+8.92%	25.49B
ALNYLAM PHARMACEUTICALS, INC.	-25.13%	18.12B
MEDPACE HOLDINGS, INC.	+29.17%	12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.12%	11.76B
UNITED THERAPEUTICS CORPORATION	+6.35%	11B

Other Biotechnology & Medical Research